NCT04294524

Management of Sleep Apnoea Syndrome (SAS) in Patients With Vasovagal Syncope (VVS)

Management of Sleep Apnoea Syndrome (SAS) in Patients With Vasovagal Syncope (VVS): a Protocol for the VVS-SAS Registry Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 60 (estimated)
• Sponsor: PEAS (Pole d'Exploration des Apnees du Sommeil) · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a multi-centre, registry-based study whose primary objective is to evaluate the effect of treatment for sleep apnoea syndrome (SAS) on the number of syncope/malaise episodes in a population suffering from both idiopathic, recurrent vasovagal syncope/malaises and SAS.

Detailed description

Treatment for sleep apnoea syndrome includes continuous positive airway pressure (CPAP) or a mandibular advancement device (MAD). Additional routine follow-up includes 24 hour holter monitoring on a yearly basis, polysomnography on a yearly basis, multiple sleep latency tests, table tilt tests.

Conditions

• Syncope, Vasovagal
• Sleep Apnea Syndromes

Interventions

Type	Name	Description
OTHER	Sleep apnea treatment	Sleep apnea treatment as decided according to routine practice. This may be Continuous positive airway pressure (CPAP) or wearing a mandibular advancement device (MAD).

Timeline

• Start date: 2017-02-22
• Primary completion: 2022-02-22
• Completion: 2022-02-22
• First posted: 2020-03-04
• Last updated: 2020-03-04

Locations

8 sites across 2 countries: France, Monaco